Compare BOOM & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOOM | STXS |
|---|---|---|
| Founded | 1965 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 164.1M |
| IPO Year | 1995 | 2004 |
| Metric | BOOM | STXS |
|---|---|---|
| Price | $6.97 | $1.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.50 | $4.00 |
| AVG Volume (30 Days) | 91.9K | ★ 530.7K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.02 | 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $609,840,000.00 | $29,346,617.00 |
| Revenue This Year | N/A | $28.22 |
| Revenue Next Year | $8.55 | $30.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.69 | $1.24 |
| 52 Week High | $9.20 | $3.59 |
| Indicator | BOOM | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 45.56 |
| Support Level | $6.62 | $1.30 |
| Resistance Level | $7.29 | $1.51 |
| Average True Range (ATR) | 0.33 | 0.06 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 34.19 | 28.12 |
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.